Positive correlation between increased tumor-infiltrating eosinophils and T-cells associated with delayed melanoma progression was observed. High baseline levels of eosinophil count, serum eosinophil cationic protein and eosinophil peroxidase were linked to prolonged progression-free survival in metastatic melanoma receiving immune checkpoint inhibition. This evidence concerns the gene EPX and neoplasm.